Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
BI-765845 by Boehringer Ingelheim International for Myocardial Infarction: Likelihood of Approval
BI-765845 is under clinical development by Boehringer Ingelheim International and currently in Phase II for Myocardial Infarction. According to GlobalData,...